IOL CHEMICALS & PHARM. | LAURUS LABS | IOL CHEMICALS & PHARM./ LAURUS LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 114.5 | 11.9% | View Chart |
P/BV | x | 1.6 | 5.7 | 27.3% | View Chart |
Dividend Yield | % | 1.0 | 0.5 | 213.2% |
IOL CHEMICALS & PHARM. LAURUS LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
LAURUS LABS Mar-23 |
IOL CHEMICALS & PHARM./ LAURUS LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 626 | 85.7% | |
Low | Rs | 272 | 287 | 94.9% | |
Sales per share (Unadj.) | Rs | 377.6 | 112.1 | 336.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 14.8 | 160.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 20.8 | 151.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.00 | 200.0% | |
Avg Dividend yield | % | 1.0 | 0.4 | 225.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 74.7 | 343.6% | |
Shares outstanding (eoy) | m | 58.71 | 538.65 | 10.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 4.1 | 26.3% | |
Avg P/E ratio | x | 17.1 | 30.9 | 55.3% | |
P/CF ratio (eoy) | x | 12.8 | 21.9 | 58.4% | |
Price / Book Value ratio | x | 1.6 | 6.1 | 25.8% | |
Dividend payout | % | 16.9 | 13.5 | 124.8% | |
Avg Mkt Cap | Rs m | 23,743 | 245,840 | 9.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 5,574 | 30.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 60,406 | 36.7% | |
Other income | Rs m | 256 | 60 | 426.8% | |
Total revenues | Rs m | 22,427 | 60,466 | 37.1% | |
Gross profit | Rs m | 2,257 | 15,922 | 14.2% | |
Depreciation | Rs m | 462 | 3,241 | 14.2% | |
Interest | Rs m | 165 | 1,652 | 10.0% | |
Profit before tax | Rs m | 1,887 | 11,089 | 17.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 3,123 | 15.9% | |
Profit after tax | Rs m | 1,391 | 7,966 | 17.5% | |
Gross profit margin | % | 10.2 | 26.4 | 38.6% | |
Effective tax rate | % | 26.2 | 28.2 | 93.2% | |
Net profit margin | % | 6.3 | 13.2 | 47.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 34,617 | 27.9% | |
Current liabilities | Rs m | 5,025 | 24,323 | 20.7% | |
Net working cap to sales | % | 20.9 | 17.0 | 122.8% | |
Current ratio | x | 1.9 | 1.4 | 135.2% | |
Inventory Days | Days | 43 | 14 | 299.2% | |
Debtors Days | Days | 8 | 10 | 87.1% | |
Net fixed assets | Rs m | 11,017 | 41,987 | 26.2% | |
Share capital | Rs m | 587 | 1,077 | 54.5% | |
"Free" reserves | Rs m | 14,490 | 39,177 | 37.0% | |
Net worth | Rs m | 15,077 | 40,255 | 37.5% | |
Long term debt | Rs m | 0 | 7,614 | 0.0% | |
Total assets | Rs m | 20,684 | 76,604 | 27.0% | |
Interest coverage | x | 12.5 | 7.7 | 161.5% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 135.9% | |
Return on assets | % | 7.5 | 12.6 | 59.9% | |
Return on equity | % | 9.2 | 19.8 | 46.6% | |
Return on capital | % | 13.6 | 26.6 | 51.1% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 22.7 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 13,720 | 0.0% | |
Fx inflow | Rs m | 5,930 | 43,470 | 13.6% | |
Fx outflow | Rs m | 6,052 | 13,720 | 44.1% | |
Net fx | Rs m | -122 | 29,750 | -0.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 9,939 | 12.3% | |
From Investments | Rs m | -1,200 | -9,961 | 12.0% | |
From Financial Activity | Rs m | -41 | -266 | 15.4% | |
Net Cashflow | Rs m | -18 | -297 | 6.2% |
Indian Promoters | % | 48.2 | 27.2 | 177.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 37.8 | 4.5% | |
FIIs | % | 1.4 | 26.0 | 5.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 72.8 | 71.2% | |
Shareholders | 130,003 | 356,830 | 36.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | LAURUS LABS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | -2.09% | 0.97% |
1-Month | 5.64% | 7.03% | 2.08% |
1-Year | -1.14% | 43.95% | 55.37% |
3-Year CAGR | -12.91% | -2.94% | 15.04% |
5-Year CAGR | 16.34% | 40.65% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the LAURUS LABS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of LAURUS LABS the stake stands at 27.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of LAURUS LABS .
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
LAURUS LABS paid Rs 2.0, and its dividend payout ratio stood at 13.5%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of LAURUS LABS .
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.